Julie Snow, MD
Obstetrics & Gynecology · Des Plaines, ILNPI 1154348720
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.7% of the total across 182 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations.
Across 182 payments — averaging $20.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$851
- Sumitomo Pharma America, Inc.$296
- Mayne Pharma Commercial LLC$268
- Pfizer$250
- Therapeuticsmd, Inc.$226
- Myovant Sciences Inc.$196
- plus $2K from 30 others
What the payments were for
- Food & beverage$3,57298%
- Education$852%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 44 | $851 |
| Sumitomo Pharma America, Inc. | 11 | $296 |
| Mayne Pharma Commercial LLC | 14 | $268 |
| Pfizer | 13 | $250 |
| Therapeuticsmd, Inc. | 12 | $226 |
| Myovant Sciences Inc. | 8 | $196 |
| Astellas Pharma US Inc | 6 | $182 |
| Novo Nordisk | 11 | $182 |
| Hologic Sales And Service, LLC | 8 | $161 |
| Coopersurgical, Inc. | 7 | $136 |
| Lilly USA, LLC | 4 | $87 |
| Shield Therapeutics Inc | 4 | $82 |
| Avion Pharmaceuticals | 4 | $70 |
| Dysis Medical, Inc. | 4 | $64 |
| Aspira Women's Health Inc | 3 | $58 |
| Millicent US Inc | 2 | $43 |
| Exact Sciences | 2 | $42 |
| Daiichi Sankyo Inc. | 2 | $41 |
| Biogen | 2 | $38 |
| Amgen | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| Exeltis, USA Inc. | 2 | $32 |
| Merck | 2 | $30 |
| Vertical Pharmaceuticals, LLC | 2 | $28 |
| Arjo Inc. | 1 | $27 |
| Medicem Inc. | 1 | $26 |
| Boston Scientific | 1 | $26 |
| Biohaven Pharmaceuticals, Inc. | 1 | $23 |
| Agile Therapeutics, Inc. | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Organon | 1 | $18 |
| Scynexis, Inc. | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Smith+Nephew | 1 | $14 |
| Ascend Therapeutics US, LLC | 1 | $14 |
| Channel Medsystems, Inc. | 1 | $9 |
How this compares
$3,657 in reported general payments places this provider in the 85th percentile of 1,732 obstetrics & gynecology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 50 | $2,827 |
| Clobetasol Propionate | 21 | $376 |
| Clobetasol EmollientClobetasol Propionate/Emoll | 15 | $352 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Des Plaines
- Lee ShulmanChicago$559K
- Anne SchaibleOak Lawn$546K
- Christopher OlsonNaperville$530K
- Maria TamChicago$378K
- Charles MillerNaperville$317K
- Gregory UrsinoChicago$242K
- Buthaina JabirNaperville$199K
- Frank TugwellSterling$140K
- Ayman Al-HendyChicago$135K
- Nicole TaskerChicago$125K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.